Skip to content

Effect of early intervention using ganglioside on radiation-induced brain injury in nasopharyngeal carcinoma patients: a multimodal MRI study

Effect of early intervention using ganglioside on radiation-induced brain injury in nasopharyngeal carcinoma patients: a multimodal MRI study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOB-15006982
Enrollment
Unknown
Registered
2015-08-27
Start date
2015-09-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radiation-induced brain injury in nasopharyngeal carcinoma after radiotherapy

Interventions

Interventional group:monosialotetrahexosylganglioside (ganglioside GM1)
control group:None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) patients who had newly confirmed by pathology, previously untreated nasopharyngeal carcinoma; (2) patients who are the Han nationality, right-handedness; (3) Between the ages of 20 and 55, education level of junior high school or above; (4) patients who will treated by intensity-modulated radiation therapy (IMRT); (5) without any other serious system disease; (6) without intracranial invasion and distant metastasis; (7) without any focal abnormality detected on routine brain MRI examinations; (8) Without a family history of mental illness; (9) without neurological or psychiatric diseases and prior substantial head trauma; (10) Participants who provided written informed consents.

Exclusion criteria

Exclusion criteria: (1) with focal abnormality detected on routine brain MRI examinations; (2) with contraindications to MRI; (3) with other major medical illness; (4) with tumor recurrence or who cannot insist on the IMRT treatment; (5) left-handedness or both-handness; (6) with a history of head injury, neurological or psychiatric diseases; (7) age lower than 20 or greater than 55 years; (8) other major medical illness; (9) hypertension, diabetes; (10) Participants who cannot cooperate to finish the neuropsychological tests.

Design outcomes

Primary

MeasureTime frame
Score of Montreal cognitive assessment scale;indices of blood oxygenation level dependent;indices of diffusion tensor imaging;indices of high-resolution three-dimensional T1WI;

Countries

China

Contacts

Public ContactXiaofei Lv
lvxf@sysucc.org.cn+86 020 87342125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026